Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.1450 (-4.73%) ($6.1450 - $6.1450) on Mon. Aug. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.79% (three month average) | RSI | 49 | Latest Price | $6.1450(-4.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(70%) ARKK(67%) IWO(65%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -1.895% in a week (0% probabilities). VIXM(-49%) VXX(-38%) UUP(-15%) TLT(-6%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.895% (StdDev 3.79%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.19(-103.09%) | Resistance Level | $6.69 | 5 Day Moving Average | $6.46(-4.88%) | 10 Day Moving Average | $6.63(-7.32%) | 20 Day Moving Average | $6.69(-8.15%) | To recent high | -30.1% | To recent low | 0% | Market Cap | $508m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |